Dexmedetomidine Improves Cognitive Impairment Induced by Hypoxic-ischemic Brain
Damage in Neonatal Rats by Activating SIRT1/BDNF Signaling Pathway

doi:10.3870/j.issn.1672-0741.2023.02.007

Acta Medicinae Universitatis Scientiae et Technologiae Huazhong ›› 2023, Vol. 52 ›› Issue (2): 181-186.doi: 10.3870/j.issn.1672-0741.2023.02.007

Previous Articles Next Articles

Dexmedetomidine Improves Cognitive Impairment Induced by Hypoxic-ischemic Brain Damage in Neonatal Rats by Activating SIRT1/BDNF Signaling Pathway

Received:2022-02-28 Online:2023-04-15 Published:2023-05-16

Abstract

CLC Number:

R722.1

Yu Dan, Chen Zhangqiang, Peng Xiaohong. Dexmedetomidine Improves Cognitive Impairment Induced by Hypoxic-ischemic Brain Damage in Neonatal Rats by Activating SIRT1/BDNF Signaling Pathway[J]. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, 2023, 52(2): 181-186.

Dexmedetomidine Improves Cognitive Impairment Induced by Hypoxic-ischemic Brain Damage in Neonatal Rats by Activating SIRT1/BDNF Signaling Pathway

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments